Best Targeted Therapy Hospitals in China

Beijing GoBroad Boren Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The accredited hospital was established in 2014 in Beijing, China and has 200 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

Shanghai GoBroad Cancer Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The accredited hospital was established in 2016 in Shanghai, China and has 700 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

With advanced oncology infrastructure, GoBroad Shanghai Zhaxin Hospital and Shanghai Liquan Hospital offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2018, the accredited hospital is located in Shanghai, China, and has 300 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

At GoBroad Healthcare (Hematology) Guangdong Research Center, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2018, the accredited hospital is located in Dongguan, China, and has 200 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.